[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
blank posts on X about $srrk, approved, $ibrx, twitter the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence social networks XXXX% technology brands XXXX% vc firms XXXX%
Social topic influence $srrk 1.75%, approved 1.75%, $ibrx 1.75%, twitter 1.75%, podcasts 1.75%, longterm 1.75%, $53m 1.75%, abingworth 1.75%, healthcap 1.75%, its just XXXX%
Top accounts mentioned or mentioned by @aaronrosenblum5 @sqwii @houndcl @realchinesespy @biofeed @amaymd @west0cap @tankadelphia @adrianh @msollender @jeremyj0916 @biopm1989 @immunitybio @andersresearch @jessebrodkin @anthonystaj @onamixt @bingbingbom @joshthe3rd @bigpharmaguy
Top assets mentioned Scholar Rock Holding Corporation Common Stock (SRRK) ImmunityBio, Inc. Common Stock (IBRX)
Top posts by engagements in the last XX hours
"$SRRK Looks like dropping on this The approved supplemental Biologics License Application (sBLA) did not include Catalent Indiana LLC as a filling site"
X Link @lifeisblank21 2025-10-08T18:42Z XXX followers, 1022 engagements
"The funniest thing about all this is dude is trying so hard to pump his products on podcasts and twitter claim FDA corruption etc. Yet amidst the best shitco market $IBRX stock is down X% YTD"
X Link @lifeisblank21 2025-10-15T02:28Z XXX followers, 1148 engagements
"@AaronRosenblum5 They raised $53M in 2023 then no raise in 2024 from anything. So I guess it's just they had no need+ during that time stock went into gutter/company was on verge of delisting. Last deal was 5am Ventures Abingworth Armistice Capital HealthCap Novo Holdings A/S etc"
X Link @lifeisblank21 2025-10-06T17:16Z XXX followers, 1034 engagements
"@Maximus_Holla Looks like they stopped developing the asset"
X Link @lifeisblank21 2025-10-07T20:04Z XXX followers, 3717 engagements